K-W Peng

832 total citations
14 papers, 689 citations indexed

About

K-W Peng is a scholar working on Genetics, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, K-W Peng has authored 14 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Epidemiology and 5 papers in Animal Science and Zoology. Recurrent topics in K-W Peng's work include Virus-based gene therapy research (12 papers), Virology and Viral Diseases (8 papers) and Animal Virus Infections Studies (5 papers). K-W Peng is often cited by papers focused on Virus-based gene therapy research (12 papers), Virology and Viral Diseases (8 papers) and Animal Virus Infections Studies (5 papers). K-W Peng collaborates with scholars based in United States, Singapore and Germany. K-W Peng's co-authors include Stephen J. Russell, Mark J. Federspiel, David Dingli, Kosei Hasegawa, Huy Ong, Allan B. Dietz, Rae Myers, Angela Dispenzieri, Yiping Liu and Shruthi Naik and has published in prestigious journals such as Cancer Research, Clinical Pharmacology & Therapeutics and Leukemia.

In The Last Decade

K-W Peng

14 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K-W Peng United States	13	590	301	291	189	178	14	689
Rebecca A. Nace United States	16	487 0.8×	250 0.8×	229 0.8×	152 0.8×	164 0.9×	30	634
Rae Myers United States	14	709 1.2×	264 0.9×	253 0.9×	266 1.4×	309 1.7×	15	846
Mary Harvey United States	11	688 1.2×	216 0.7×	256 0.9×	248 1.3×	389 2.2×	14	889
Sascha Bossow Germany	16	763 1.3×	421 1.4×	388 1.3×	234 1.2×	289 1.6×	32	1.1k
Christian Grossardt Germany	9	531 0.9×	360 1.2×	203 0.7×	148 0.8×	146 0.8×	10	645
László K. Csatáry United States	10	451 0.8×	167 0.6×	197 0.7×	180 1.0×	228 1.3×	12	570
Sandra Nishikawa Canada	13	615 1.0×	212 0.7×	276 0.9×	100 0.5×	117 0.7×	18	815
Christine E. Engeland Germany	18	792 1.3×	674 2.2×	385 1.3×	168 0.9×	169 0.9×	38	1.1k
Laurent Deleu Germany	11	391 0.7×	169 0.6×	265 0.9×	145 0.8×	67 0.4×	13	543
Candice Willmon United States	11	566 1.0×	409 1.4×	272 0.9×	75 0.4×	65 0.4×	17	683

Countries citing papers authored by K-W Peng

Since Specialization

Citations

This map shows the geographic impact of K-W Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K-W Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K-W Peng more than expected).

Fields of papers citing papers by K-W Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K-W Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K-W Peng. The network helps show where K-W Peng may publish in the future.

Co-authorship network of co-authors of K-W Peng

This figure shows the co-authorship network connecting the top 25 collaborators of K-W Peng. A scholar is included among the top collaborators of K-W Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K-W Peng. K-W Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Liu, MC, et al.. (2019). Abstract P6-21-03: Phase I trial of intratumoral (IT) administration of a NIS-expressing derivative manufactured from a genetically engineered strain of measles virus (MV). Cancer Research. 79(4_Supplement). P6–21. 5 indexed citations

Dispenzieri, Angela, Chin Voon Tong, Betsy LaPlant, et al.. (2017). Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma. Leukemia. 31(12). 2791–2798. 121 indexed citations

Suksanpaisan, Lukkana, et al.. (2013). Oral contrast enhances the resolution of in-life NIS reporter gene imaging. Cancer Gene Therapy. 20(11). 638–641. 12 indexed citations

Yarde, Danielle N., Shruthi Naik, Rebecca A. Nace, et al.. (2013). Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Therapy. 20(11). 616–621. 13 indexed citations

Liu, Yiping, et al.. (2013). Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Cancer Gene Therapy. 20(10). 582–589. 54 indexed citations

Stripecke, Renata, et al.. (2013). The innovative evolution of cancer gene and cellular therapies. Cancer Gene Therapy. 20(3). 141–149. 14 indexed citations

Naik, Shruthi, Rebecca A. Nace, Mark J. Federspiel, et al.. (2012). Curative one-shot systemic virotherapy in murine myeloma. Leukemia. 26(8). 1870–1878. 69 indexed citations

Liu, Yiping, Chin Voon Tong, Angela Dispenzieri, et al.. (2011). Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus. Cancer Gene Therapy. 19(3). 202–211. 25 indexed citations

Dingli, David, Catherine A. Offord, Rae Myers, et al.. (2009). Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Therapy. 16(12). 873–882. 56 indexed citations

10.

Myers, Rae, Suzanne Greiner, Guy E. Griesmann, et al.. (2007). Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide. Clinical Pharmacology & Therapeutics. 82(6). 700–710. 105 indexed citations

11.

Peng, K-W, Elizabeth M. Hadac, Barry Anderson, et al.. (2006). Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Therapy. 13(8). 732–738. 52 indexed citations

12.

Ong, Huy, Kosei Hasegawa, Allan B. Dietz, Stephen J. Russell, & K-W Peng. (2006). Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Therapy. 14(4). 324–333. 104 indexed citations

13.

Kanerva, Anna, Kurt R. Zinn, K-W Peng, et al.. (2004). Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Therapy. 12(1). 87–94. 47 indexed citations

14.

Johnson, Keith, K-W Peng, Cornell Allen, Stephen J. Russell, & Evanthia Galanis. (2003). Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease–substrate interaction. Gene Therapy. 10(9). 725–732. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact